InvestSMART

TrivarX Ltd (ASX: TRI) - Announcements

- Current share price for TRI : $0.012

ASX company news and announcements for TrivarX Ltd (TRI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All TrivarX Ltd (TRI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than TrivarX Ltd (TRI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for TrivarX Ltd (TRI)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$14 June 2024 Quarterly Activities Report and Appendix 4C 31 Jul 2024 1:49PM $0.032 $0.012 fallen by 62.50%
$14 Initial Director's Interest Notice - Tony Keating 30 Jul 2024 9:27AM $0.036 $0.012 fallen by 66.67%
$14 Final Director's Interest Notice - Tom Young 30 Jul 2024 9:26AM $0.036 $0.012 fallen by 66.67%
$14 TechKnow Invest Roadshow presentation and livestream links 30 Jul 2024 9:24AM $0.036 $0.012 fallen by 66.67%
$14 Positive Results from Phase 2 SAMDE Study 30 Jul 2024 9:07AM $0.036 $0.012 fallen by 66.67%
$14 Trading Halt 29 Jul 2024 8:46AM $0.036 $0.012 fallen by 66.67%
$14 Appointment of Dr Tony Keating & Resignation of Dr Tom Young 29 Jul 2024 8:30AM $0.036 $0.012 fallen by 66.67%
$14 Change in substantial holding 12 Jul 2024 4:22PM $0.035 $0.012 fallen by 65.71%
$14 Change of Director's Interest Notice - David Trimboli 10 Jul 2024 10:00AM $0.028 $0.012 fallen by 57.14%
$14 Change of Director's Interest Notice - Chris Ntoumenopoulos 10 Jul 2024 10:00AM $0.028 $0.012 fallen by 57.14%
$14 Cleansing Notice 10 Jul 2024 9:55AM $0.028 $0.012 fallen by 57.14%
$14 Application for quotation of securities - TRI 10 Jul 2024 9:49AM $0.028 $0.012 fallen by 57.14%
$14 Application for quotation of securities - TRI 10 Jul 2024 9:45AM $0.028 $0.012 fallen by 57.14%
$14 Notification regarding unquoted securities - TRI 10 Jul 2024 9:45AM $0.028 $0.012 fallen by 57.14%
$14 Notification regarding unquoted securities - TRI 10 Jul 2024 9:40AM $0.028 $0.012 fallen by 57.14%
$14 Application for quotation of securities - TRI 10 Jul 2024 9:27AM $0.028 $0.012 fallen by 57.14%
$14 Completion of Phase 2 SAMDE Trial 10 Jul 2024 8:25AM $0.028 $0.012 fallen by 57.14%
$14 Proposed issue of securities - TRI 9 Jul 2024 2:34PM $0.028 $0.012 fallen by 57.14%
$14 Results of General Meeting 5 Jul 2024 11:24AM n/a $0.012 n/a
$14 TrivarX SAMDE Trial Update 20 Jun 2024 8:24AM $0.025 $0.012 fallen by 52%
$14 Update - Proposed issue of securities - TRI 11 Jun 2024 9:10AM $0.028 $0.012 fallen by 57.14%
$14 Proposed issue of securities - TRI 4 Jun 2024 10:48AM $0.026 $0.012 fallen by 53.85%
$14 Letter to Shareholders & Notice of GM & Proxy Form 4 Jun 2024 10:33AM $0.026 $0.012 fallen by 53.85%
$14 Presentation - Investor Webinar 22 May 2024 9:57AM $0.027 $0.012 fallen by 55.56%
$14 Investor Webinar 22 May 2024 9:54AM $0.027 $0.012 fallen by 55.56%

126 - 150 of 208 results

Page 6 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.